Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer

  • Authors:
    • Sharad S. Singhal
    • Jyotsana Singhal
    • Maya P. Nair
    • A. G. Lacko
    • Yogesh C. Awasthi
    • Sanjay Awasthi
  • View Affiliations

  • Published online on: March 1, 2007     https://doi.org/10.3892/ijo.30.3.717
  • Pages: 717-725
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

RALBP1 (RLIP76) is the major transporter of doxorubicin (DOX) in lung cancer cells, and that the difference in sensitivity of small cell lung cancer (SCLC) cells to DOX is due to differential phosphorylation by PKCα. Our recent studies have suggested that RALBP1 present in MCF-7 breast cancer cells has significantly lower specific activity for transport of DOX than wild-type recombinant protein, and its level of expression is significantly lower than that in lung cancer cells. In the present study, we have explored whether or not this is a generalized phenomenon for breast cancer, and have compared the relative contributions of RALBP1 and the ABC-family transporter, ABCG2 to total DOX transport activities in two SCLC (H1417 and H1618), two non-small cell lung cancer (NSCLC) (H358 and H520), and three breast cancer (T-47D, MDA-MB231, and MCF-7) cell lines. Results of these studies show lower protein expression and specific activity of RALBP1 in all three breast cancer cell lines as compared with lung cancer cell lines. Furthermore, we demonstrate that RALBP1 contributes only a minor fraction of DOX transport activity in breast cancer cell lines, suggesting that greater DOX sensitivity of breast cancer may be related to lower RALBP1 transporter activity and that the transport mechanisms involved in multidrug resistance of lung and breast cancer are distinct.

Related Articles

Journal Cover

March 2007
Volume 30 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Singhal SS, Singhal J, Nair MP, Lacko AG, Awasthi YC and Awasthi S: Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. Int J Oncol 30: 717-725, 2007
APA
Singhal, S.S., Singhal, J., Nair, M.P., Lacko, A.G., Awasthi, Y.C., & Awasthi, S. (2007). Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. International Journal of Oncology, 30, 717-725. https://doi.org/10.3892/ijo.30.3.717
MLA
Singhal, S. S., Singhal, J., Nair, M. P., Lacko, A. G., Awasthi, Y. C., Awasthi, S."Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer". International Journal of Oncology 30.3 (2007): 717-725.
Chicago
Singhal, S. S., Singhal, J., Nair, M. P., Lacko, A. G., Awasthi, Y. C., Awasthi, S."Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer". International Journal of Oncology 30, no. 3 (2007): 717-725. https://doi.org/10.3892/ijo.30.3.717